好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Temporal Trends in Peripheral Neuropathy-Related Mortality in the United States: A 1999- 2020 Analysis
General Neurology
P5 - Poster Session 5 (8:00 AM-9:00 AM)
2-006
To assess trends in peripheral neuropathy-related mortality in the United States from 1999 to 2020 across various demographic factors.

Peripheral neuropathy is a widespread neurological condition characterized by damage to the peripheral nerves, leading to sensory and motor dysfunction that can severely impact quality of life.

Trends in peripheral neuropathy-related mortality among individuals aged 25 years and older were analyzed utilizing data from the Centers for Disease Control and Prevention's Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database. Peripheral neuropathy was identified as a multiple cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population and the annual percentage change (APC) were calculated, stratified by gender, race, age group, and geographic region.

A total of 61,414 peripheral neuropathy-related deaths were identified over the study period. Mortality rose by 58%, with the AAMR increasing from 1.2 in 1999 to 1.9 in 2020 (AAPC: 2.4 [95% CI: 1.9, 2.9]). While males had higher AAMRs (1.6) compared to females (1), the rate of increase was more pronounced among females (AAPC: 2.7 [95% CI: 2.2, 3.3]). Older adults (5.25) had an AAMR 17.5 times greater than younger adults (0.3). Non-Hispanic Whites (5.76) exhibited the highest AAMRs, followed by non-Hispanic Blacks (3.2), non-Hispanic American Indians (1.8), and Hispanics (0.67). Non-metropolitan areas had a higher AAMR (1.5) compared to metropolitan areas (1.2). Regionally, the West recorded the highest AAMR (1.5), while the Northeast reported the lowest (0.93). States in the top 90th percentile of AAMRs included Colorado, Oregon, Wyoming, Minnesota, and Nebraska.

The increasing mortality from peripheral neuropathy across diverse populations highlights the urgent need for targeted research and intervention. Addressing these trends is critical to improving outcomes and reducing the burden on affected individuals and communities.

Authors/Disclosures
Shayan Marsia, MBBS
PRESENTER
Dr. Marsia has nothing to disclose.
Ifrah Ansari Miss Ansari has nothing to disclose.
Ruqiat M. Batool Ms. Batool has nothing to disclose.
Zainab Siddiqua Ibrahim, MBBS Dr. Ibrahim has nothing to disclose.
Sayed Mustafa M. Shah, MBBS (Missouri University Healthcare) Dr. Shah has nothing to disclose.
Rameez A. Merchant, MBBS Dr. Merchant has nothing to disclose.